Increased chromosomal instability in peripheral lymphocytes and risk of human gliomas.

Brain tumors exhibit considerable chromosome instability (CIN), suggesting that genetic susceptibility may contribute to brain tumorigenesis. To test this hypothesis, in this pilot study, we examined for CIN in short-term lymphocyte cultures from 25 adult glioma patients and 28 age-, sex- and ethnicity-matched healthy controls (all Caucasian). We evaluated CIN by a multicolor fluorescence in situ hybridization assay using two probes: a classic satellite probe for a large heterochromatin breakage-prone region of chromosome 1 and an alpha satellite probe for a smaller region adjacent to the heterochromatin probe. Our results showed a significant increase in the mean number of spontaneous breaks per 1000 cells in glioma patients (mean +/- SD, 2.4+/-0.8) compared with controls (1.4+/-0.9; P < 0.001). By using the median number of breaks per 1000 cells in the controls as the cutoff value, we observed a crude odds ratio (OR) of 8.5 [95% confidence interval (CI) = 2.05-34.9, P < 0.001] for spontaneous breaks and brain tumor risk. After adjustment for age, sex and smoking status, the adjusted OR was 15.3 (95% CI, 2.71-87.8). A significant increase in cells with chromosome 1 aneuploidy (in the form of hyperdiploidy) (P < 0.001) was also observed in the glioma cases, with an adjusted OR of 6.6 (95% CI = 1.5-30, P < 0.05). These findings suggest that CIN can be detected in the peripheral blood lymphocytes of brain tumor patients and may be a marker for identifying individuals at risk.

[1]  P. Duesberg,et al.  Genetic instability of cancer cells is proportional to their degree of aneuploidy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Z. Abdel‐Rahman,et al.  Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. , 1998, Mutation research.

[3]  S. Brem,et al.  Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. , 1998, Journal of neurosurgery.

[4]  M. Duffy Cancer metastasis: Biological and clinical aspects , 1998, Irish journal of medical science.

[5]  J. Kros,et al.  Detection of Chromosomal Changes by Interphase Cytogenetics in Biopsies of Recurrent Astrocytomas and Oligodendrogliomas , 1997, Journal of neuropathology and experimental neurology.

[6]  S. Z. Abdel‐Rahman,et al.  Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers. , 1997, Mutation research.

[7]  C. Wernicke,et al.  Numerical aberrations of chromosomes 1, 2, and 7 in astrocytomas studied by interphase cytogenetics , 1997, Genes, chromosomes & cancer.

[8]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[9]  A. Grosovsky,et al.  Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability , 1996, Molecular and cellular biology.

[10]  J. Bruner,et al.  Mutagen sensitivity and risk of gliomas: a case-control analysis. , 1996, Cancer research.

[11]  K. Mrózek,et al.  Accumulation of chromosomal changes in human glioma progression. A cytogenetic study of 50 cases. , 1995, Cancer genetics and cytogenetics.

[12]  G. Mohapatra,et al.  Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.

[13]  T. Ono,et al.  Loss of heterozygosity at 11p15 in malignant glioma. , 1995, Cancer research.

[14]  D. Frappaz,et al.  Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. comparison with restriction fragment length polymorphism and conventional cytogenetic analyses , 1995, International journal of cancer.

[15]  D. Eastmond,et al.  Detection of chromosomal breakage in the 1cen-1q12 region of interphase human lymphocytes using multicolor fluorescence in situ hybridization with tandem DNA probes. , 1995, Cancer research.

[16]  W. Cavenee,et al.  Genetics and malignant progression of human brain tumours. , 1995, Cancer surveys.

[17]  G. Broggi,et al.  Increasing complexity of the karyotype in 50 human gliomas. Progressive evolution and de novo occurrence of cytogenetic alterations. , 1994, Cancer genetics and cytogenetics.

[18]  D. Eastmond,et al.  Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. , 1994, Mutation research.

[19]  J. Rey,et al.  Molecular analysis of chromosomh 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors , 1994, International journal of cancer.

[20]  A. Grosovsky,et al.  Genetic instability on chromosome 16 in a human B lymphoblastoid cell line , 1993, Somatic cell and molecular genetics.

[21]  A. Raap,et al.  Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. , 1992, Journal of neurosurgery.

[22]  Y. Nakamura,et al.  Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. , 1989, Cancer research.

[23]  D. Johnston,et al.  Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis , 1989, International journal of cancer.

[24]  A. Agresti,et al.  In situ hybridization analysis of interstitial C-heterochromatin in marker chromosomes of two human melanomas. , 1989, Cancer research.

[25]  A. Cordier,et al.  New trends in genetic risk assessment , 1989 .

[26]  B. Dutrillaux,et al.  12 – Specific Sites of Chromosomal Radiation-induced Rearrangements , 1989 .

[27]  D. Bigner,et al.  Specific chromosomal abnormalities in malignant human gliomas. , 1988, Cancer research.

[28]  L. Larizza,et al.  C-heterochromatin variation and transposition in tumor progression. , 1988, Advances in experimental medicine and biology.

[29]  Yunis Jj,et al.  Fragile sites are targets of diverse mutagens and carcinogens. , 1987 .

[30]  J. Yunis,et al.  Fragile sites are targets of diverse mutagens and carcinogens. , 1987, Oncogene.

[31]  P. Nowell Mechanisms of tumor progression. , 1986, Cancer research.

[32]  U. G. Dailey Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.